Functional analysis of activated C1s, a subcomponent of the first component of human complement, by monoclonal antibodies
- PMID: 2428878
Functional analysis of activated C1s, a subcomponent of the first component of human complement, by monoclonal antibodies
Abstract
Three mouse monoclonal antibodies (M365, M81, and M241) directed against human C1s were used to analyze the structure of C1s related to the enzymatic activity. M365 and M81 recognized different epitopes on the heavy chain of C1s and could bind to C1s, as well as to C1s. The C4 cleaving activity of C1s was completely blocked by M81 and was partially blocked by M365. Although the C2 cleaving activity of C1s was partially inhibited by M81, no blocking was observed with M365. Both antibodies had no effect on the esterolytic activity of C1s. These results indicate that the C4 and C2 binding sites on C1s reside in the heavy chain, and they are distinct from each other. M241 could bind only to C1s, an active form of C1s. After reduction of C1s, M241 could not react with either heavy or light chain of C1s. The esterolytic activity of C1s was markedly reduced by M241. Furthermore, M241 blocked not only the cleavage of C4 and C2 by C1s but also the complex formation of C1s and C1 inactivator. From these observations, we suggest that M241 reacts with the active site of C1s, and both heavy and light chains of C1s participate in the composition of the active site.
Similar articles
-
Probing the C4-binding site on C1s with monoclonal antibodies. Evidence for a C4/C4b-binding site on the gamma-domain.J Immunol. 1989 Apr 15;142(8):2743-50. J Immunol. 1989. PMID: 2522968
-
Antibody-independent C1 activation by E. coli.J Immunol. 1984 Aug;133(2):886-91. J Immunol. 1984. PMID: 6376630
-
Comparative study of the fluid-phase proteolytic cleavage of human complement subcomponents C4 and C2 by C1s and C1r2-C1s2.FEBS Lett. 1984 Jan 2;165(1):111-6. doi: 10.1016/0014-5793(84)80025-3. FEBS Lett. 1984. PMID: 6319179
-
The structure and function of the first component of complement: genetic engineering approach (a review).Acta Microbiol Immunol Hung. 1994;41(4):361-80. Acta Microbiol Immunol Hung. 1994. PMID: 7866721 Review.
-
Inherited complement deficiency states and SLE.Clin Rheum Dis. 1982 Apr;8(1):29-47. Clin Rheum Dis. 1982. PMID: 6288318 Review. No abstract available.
Cited by
-
Complement C1q activates canonical Wnt signaling and promotes aging-related phenotypes.Cell. 2012 Jun 8;149(6):1298-313. doi: 10.1016/j.cell.2012.03.047. Cell. 2012. PMID: 22682250 Free PMC article.
-
Complement C1s activation in degenerating articular cartilage of rheumatoid arthritis patients: immunohistochemical studies with an active form specific antibody.Ann Rheum Dis. 1999 Mar;58(3):175-81. doi: 10.1136/ard.58.3.175. Ann Rheum Dis. 1999. PMID: 10364916 Free PMC article.
-
Antibody-independent classical complement pathway activation and homologous C3 deposition in xeroderma pigmentosum cell lines.Clin Exp Immunol. 1999 Jun;116(3):547-53. doi: 10.1046/j.1365-2249.1999.00923.x. Clin Exp Immunol. 1999. PMID: 10361249 Free PMC article.
-
Purification and characterization of a human membrane protein that activates the alternative complement pathway and allows the deposition of homologous complement C3.J Exp Med. 1995 Jan 1;181(1):115-25. doi: 10.1084/jem.181.1.115. J Exp Med. 1995. PMID: 7806998 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous